Professional Documents
Culture Documents
Coronavirus Disease (COVID-19) : Situation Report - 199
Coronavirus Disease (COVID-19) : Situation Report - 199
(COVID-19)
Situation Report – 199
Data as received by WHO from national authorities by 10:00 CEST, 6 August 2020
Highlights
The WHO Regional Office for the Americas has issued a warning against the use of chlorine
products as treatment for COVID-19. WHO recommends that people avoid consuming products
containing chlorine dioxide or related substances (sodium hypochlorite, bleach, etc.) and that
all marketing of such products for therapeutic purposes be reported to the authorities.
The South African COVID-19 response is being bolstered by a surge team of health experts
from WHO. The surge team will be jointly led by Dr Matshidiso Moeti, WHO Regional Director
for Africa and Dr Michael Ryan, Executive Director of the WHO Health Emergencies Programme.
Forty-three experts from various fields will be deployed to support the COVID-19 outbreak
response management.
The WHO Regional Office for South-East Asia has urged countries in the region to maintain
essential healthcare and accelerate the resumption of services that have been disrupted, by the
pandemic, as an integral part of the COVID-19 response. Since the outbreak of COVID-19,
repurposing of health workers, cancellation of elective care, closure of outpatient services,
insufficient personal protective equipment, and changes in treatment policy have significantly
impacted the delivery of essential services.
Globally 18 614 177 cases (259 344) 702 642 deaths (6 488)
Africa 848 053 cases (13 906) 15 252 deaths (502)
Americas 9 981 204 cases (139 362) 372 008 deaths (4 074)
Eastern Mediterranean 1 598 640 cases (13 182) 42 052 deaths (451)
Europe 3 477 225 cases (25 178) 215 168 deaths (430)
South-East Asia 2 360 721 cases (61 288) 49 572 deaths (1 003)
Western Pacific 347 593 cases (6 428) 8 577 deaths (28)
Subject in Focus: Global Multidisciplinary Platform Discussion on
SARS-CoV-2 Modes of Transmission
Understanding transmission of SARS-CoV-2, the virus that causes COVID-19, was identified
as a priority for research since the beginning of the pandemic and the February and July
2020 global R&D Blueprint meetings reiterated this priority. The meeting this week
brought together researchers to present the latest scientific evidence and identify
knowledge gaps and best methods to undertake the high-quality comprehensive research
studies to better understand how, when and where transmission of the virus occurs. The
discussion included perspectives from experts in the fields of public health, infectious
respiratory diseases, virology, engineering and physical sciences, epidemiology,
phylogenetics, clinical management, social sciences, and infection prevention and control.
WHO will summarize the discussions and conclusions in a future publication. It will also
work with experts to develop further standardized protocols outlining the best research
methodologies, and seek funding opportunities with partners to support investigations in
this important area.
Current WHO Modes of Transmission research published 9 July 2020 is available online
at:https://www.who.int/news-room/commentaries/detail/transmission-of-sars-cov-2-
implications-for-infection-prevention-precautions
WHO standardized study protocols for COVID-19 are available at:
https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-
guidance/early-investigations
Surveillance
Figure 1. Number of confirmed* COVID-19 cases reported in the last seven days by country, territory or area, 31 July to 6 August **
64 0 0 0 Sporadic cases 1
French Polynesia
Northern Mariana Islands 46 0 2 0 Pending 2
(Commonwealth of the)
New Caledonia 22 0 0 0 Sporadic cases 22
Subtotal for all regions 18 613 436 259 344 702 629 6 488
Other† 741 0 13 0 Not applicable -
Grand total 18 614 177 259 344 702 642 6 488
**See Annex 1 for data, table and figure notes.
Technical guidance and other resources
– To view all technical guidance documents regarding COVID-19, please go to this webpage.
– Updates from WHO regional offices
Case definitions
WHO periodically updates the Global Surveillance for human infection with coronavirus
disease (COVID-19) document which includes surveillance definitions.
A COVID-19 death is defined for surveillance purposes as a death resulting from a clinically
compatible illness in a probable or confirmed COVID-19 case, unless there is a clear
alternative cause of death that cannot be related to COVID-19 disease (e.g. trauma). There
should be no period of complete recovery between the illness and death.
Further guidance for certification and classification (coding) of COVID-19 as cause of death is
available here and here.
Annex 1: Data, table and figure notes
Caution must be taken when interpreting all data presented. Differences are to be expected
between information products published by WHO, national public health authorities, and
other sources using different inclusion criteria and different data cut-off times. While steps
are taken to ensure accuracy and reliability, all data are subject to continuous verification and
change. Case detection, definitions, testing strategies, reporting practice, and lag times differ
between countries/territories/areas. These factors, amongst others, influence the counts
presented, with variable underestimation of true case and death counts, and variable delays
to reflecting these data at global level.
The designations employed, and the presentation of these materials do not imply the
expression of any opinion whatsoever on the part of WHO concerning the legal status of
any country, territory or area or of its authorities, or concerning the delimitation of its
frontiers or boundaries. Dotted and dashed lines on maps represent approximate border
lines for which there may not yet be full agreement. Countries, territories and areas are
arranged under the administering WHO region.
The mention of specific companies or of certain manufacturers’ products does not imply
that they are endorsed or recommended by WHO in preference to others of a similar
nature that are not mentioned. Errors and omissions excepted, the names of proprietary
products are distinguished by initial capital letters.
[1]
All references to Kosovo should be understood to be in the context of the United Nations
Security Council resolution 1244 (1999). In the map, number of cases of Serbia and Kosovo
(UNSCR 1244, 1999) have been aggregated for visualization purposes.
*
A small number of countries/territories/areas report combined probable and laboratory-
confirmed cases; efforts are underway to identify these for notation in the data table.†Other:
includes cases reported from international conveyances.
Due to the recent trend of countries conducting data reconciliation exercises which remove
large numbers of cases or deaths from their total counts, WHO will now display such data as
negative numbers in the “new cases” / “new deaths” columns as appropriate. This will aid
readers in identifying when such adjustments occur. When additional details become
available that allow the subtractions to be suitably apportioned to previous days, graphics will
be updated accordingly. Prior situation reports will not be edited; see covid19.who.int for the
most up-to-date data.
i
Transmission classification is based on a process of country/territory/area self-reporting.
Classifications are reviewed on a weekly basis and may be revised as new information
becomes available. Differing degrees of transmission may be present within
countries/territories/areas; classification is based on the highest category reported within
a country/territory/area. Categories: